| Title: |
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL |
| Authors: |
Cherng, Hua-Jay J., Alig, Stefan K., Oki, Yasuhiro, Nastoupil, Loretta J., Fayad, Luis, Neelapu, Sattva S., Turturro, Francesco, Hagemeister, Fredrick, Craig, Alexander F. M., Macaulay, Charles W., Rodriguez, Maria Alma, Lee, Hun Ju, McDonnell, Timothy J., Flowers, Christopher R., Vega, Francisco, Green, Michael R., Feng, Lei, Kurtz, David M., Alizadeh, Ash A., Davis, R. Eric, Westin, Jason R. |
| Source: |
In Blood Advances 11 April 2023 7(7):1137-1145 |
| Database: |
ScienceDirect |
